"metastatic tumor" trang 6 - tải miễn phí từ tailieuXANH
Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
12    73    0
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: A rare case report and literature review

Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: A rare case report and literature review
7    69    0
Abiraterone acetate plus prednisone for the Management of Metastatic CastrationResistant Prostate Cancer (mCRPC) without prior use of chemotherapy: Report from a large, international, real-world retrospective cohort study

Abiraterone acetate plus prednisone for the Management of Metastatic CastrationResistant Prostate Cancer (mCRPC) without prior use of chemotherapy: Report from a large, international, real-world retrospective cohort study
12    68    0
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: A retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: A retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy
10    55    0
CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMTlike process

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMTlike process
18    51    0
Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study

Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study
13    77    0
Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment

Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment
10    58    0
Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France
11    85    0
Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells

Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells
24    50    0
Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis

Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis
9    63    0
The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: A retrospective study

The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: A retrospective study
8    52    0
Comparative sequence analysis of patientmatched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy

Comparative sequence analysis of patientmatched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy
11    49    0
First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: A systematic review and meta-analysis

First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: A systematic review and meta-analysis
12    67    0
Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: The TERRITOIRE study

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: The TERRITOIRE study
8    58    0
Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma

Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma
10    62    0
Combination of gemcitabine and docetaxel: A regimen overestimated in refractory metastatic osteosarcoma?

Combination of gemcitabine and docetaxel: A regimen overestimated in refractory metastatic osteosarcoma?
7    69    0
Genomic alterations accompanying tumour evolution in colorectal cancer: Tracking the differences between primary tumours and synchronous liver metastases by wholeexome sequencing

Genomic alterations accompanying tumour evolution in colorectal cancer: Tracking the differences between primary tumours and synchronous liver metastases by wholeexome sequencing
13    67    0
A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer
10    70    0
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen
8    50    0
Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: A retrospective study in mFOLFOX6 -treated patients

Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: A retrospective study in mFOLFOX6 -treated patients
8    48    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.